Kingdon Capital Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-34,250
| Closed | -$6.05M | – | 87 |
|
|
2023
Q1 | $6.05M | Sell |
34,250
-2,778
| -8% | -$491K | 1.14% | 29 |
|
|
2022
Q4 | $14.3M | Hold |
37,028
| – | – | 2.85% | 12 |
|
|
2022
Q3 | $12.5M | Buy |
37,028
+4,167
| +13% | +$1.4M | 1.6% | 11 |
|
|
2022
Q2 | $10.8M | Hold |
32,861
| – | – | 1.83% | 11 |
|
|
2022
Q1 | $14.4M | Buy |
32,861
+8,333
| +34% | +$3.64M | 1.5% | 13 |
|
|
2021
Q4 | $10.8M | Buy |
24,528
+4,648
| +23% | +$2.04M | 1.24% | 22 |
|
|
2021
Q3 | $11.1M | Buy |
19,880
+7,875
| +66% | +$4.38M | 1.35% | 20 |
|
|
2021
Q2 | $6.17M | Sell |
12,005
-8,178
| -41% | -$4.2M | 0.71% | 38 |
|
|
2021
Q1 | $15.8M | Buy |
20,183
+2,778
| +16% | +$2.17M | 1.61% | 12 |
|
|
2020
Q4 | $9.48M | Hold |
17,405
| – | – | 1.03% | 23 |
|
|
2020
Q3 | $7.97M | Hold |
17,405
| – | – | 0.9% | 30 |
|
|
2020
Q2 | $10.7M | Buy |
17,405
+4,019
| +30% | +$2.47M | 0.97% | 25 |
|
|
2020
Q1 | $6.37M | Buy |
13,386
+287
| +2% | +$136K | 1.17% | 29 |
|
|
2019
Q4 | $7.6M | Buy |
13,099
+5,271
| +67% | +$3.06M | 1.14% | 25 |
|
|
2019
Q3 | $5.15M | Buy |
7,828
+2,259
| +41% | +$1.49M | 0.61% | 38 |
|
|
2019
Q2 | $4.31M | Buy |
+5,569
| New | +$4.31M | 0.42% | 49 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 126 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 127 |
|